Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 178 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery.

Acute Kidney Injury Following Cardiac Surgery Phase2 Germany
Spain
Hungary
Argentina
Brazil
Belgium
France
Czechia
Singapore
Taiwan
Estonia
View All

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

Chronic Spontaneous Urticaria Phase3 United States
Turkey
Thailand
Spain
Italy
China
Germany
Argentina
Netherlands
Hong Kong
Japan
Malaysia
Poland
Canada
South Africa
Chile
Singapore
View All

A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea

Graft-versus-Host Disease Korea, Republic of

Secukinumab Open Label Roll-over Extension Protocol

Autoimmunity, Inflammation Phase4 United States
China
Brazil
Bulgaria
View All

Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria

Uncomplicated Plasmodium Falciparum Malaria Phase2 Côte D'Ivoire
Burkina Faso
Congo, The Democratic Republic of the
Mali
Gabon
View All

Characterizing the Use of Ofatumumab in a Real World Setting

Relapsing Multiple Sclerosis Australia

Regulatory Post-Marketing Surveillance Study for Brolucizumab

Neovascular Age-related Macular Degeneration Korea, Republic of

Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa Phase2 United States
France
Spain
Germany
Belgium
Hungary
Austria
View All

Long-term Efficacy, Safety and Tolerability of LNP023 in C3G

C3 Glomerulopathy Phase3 Turkey
Japan
China
Switzerland
Argentina
Germany
Greece
United States
Netherlands
United Kingdom
Spain
France
Israel
Italy
Brazil
View All

A Phase I/II, Open-label, Multi-center Study of [225Ac]Ac-PSMA-R2 in Men With PSMA-positive Prostate Cancer With or Without Prior 177Lu-PSMA Radioligand Therapy.

Metastatic Castration-resistant Prostate Cancer (mCRPC) Phase1, Phase2 France